Cotinga Pharmaceuticals Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Cotinga Pharmaceuticals's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Jan 2020 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses BreakdownBeta
How Cotinga Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jan 20 | 0 | -3 | 2 | 0 |
| 31 Oct 19 | 0 | -2 | 2 | 0 |
| 31 Jul 19 | 0 | -2 | 2 | 0 |
| 30 Apr 19 | 0 | -3 | 2 | 0 |
| 31 Jan 19 | 0 | -3 | 2 | 0 |
| 31 Oct 18 | 0 | -4 | 3 | 0 |
| 31 Jul 18 | 0 | -6 | 3 | 0 |
| 30 Apr 18 | 0 | -5 | 4 | 0 |
| 31 Jan 18 | 0 | -5 | 4 | 0 |
| 31 Oct 17 | 0 | -5 | 4 | 0 |
| 31 Jul 17 | 0 | -4 | 4 | 0 |
| 30 Apr 17 | 0 | -6 | 4 | 0 |
| 31 Jan 17 | 0 | -7 | 4 | 0 |
| 31 Oct 16 | 0 | -6 | 3 | 0 |
| 31 Jul 16 | 0 | -6 | 3 | 0 |
Quality Earnings: Insufficient data to determine if COTQ.F has high quality earnings.
Growing Profit Margin: Insufficient data to determine if COTQ.F's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if COTQ.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare COTQ.F's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if COTQ.F's earnings growth over the past year exceeded the Biotechs industry average.
Return on Equity
High ROE: COTQ.F has a negative Return on Equity (0%), as it is currently unprofitable.